35 results
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
. In addition, in the event the Company fails to raise a full $4,500,000 in the Rights Offering, SRO LLC agreed to a backstop commitment pursuant … ”), where he directed a new five-year $221.9 million institutional commitment for cancer center research under a new NCI-approved cancer consortium
8-K
SHPH
Shuttle Pharmaceuticals Holdings Inc
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
to raise a full $4,500,000 in the Rights Offering, SRO LLC agreed to a backstop commitment pursuant to which it would have the right to purchase any … and will act as placement agent, on a best efforts basis, for the Rights Offering. In exchange for its services, BSL will receive a commitment fee equal
8-K
EX-10.2
9iywb dc9d51oa0l
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
8-K
EX-99.1
5ypaa4opi35lst9
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
8-K
EX-10.1
x51c5 n25gz4fxvcp
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
8-K
EX-10.1
rkej yrq56
5 Feb 24
Entry into a Material Definitive Agreement
4:25pm
424B3
4azaw7b
24 Aug 23
Prospectus supplement
2:00pm
10-Q
l96lz wlje
14 Nov 22
Quarterly report
5:21pm
DRS
8s36w8sg m0
29 Sep 22
Draft registration statement
12:00am
8-K
qd4qv
6 Sep 22
Shuttle Pharmaceuticals Announces Closing of Initial Public Offering
9:14am
424B4
rs0 lkpxfw6
31 Aug 22
Prospectus supplement with pricing info
6:16am
UPLOAD
mb2g4ybdxckdjajr8zp
31 Aug 22
Letter from SEC
12:00am